Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-24 @ 4:08 PM
NCT ID:
NCT05568966
Eligibility Criteria:
Inclusion Criteria
* Subject 18 years of age.
* Willing and able to provide written informed consent and comply with study procedures.
* Patients attending a definitive care team with research capabilities which has been enroled in this collection study.
* Patients who can read and understand written English.
* The subject must present as one of the following cohorts:
1. Group A - Embolism Cohort - Patients presenting with symptoms indicative of thromboembolic events.
2. Group B - Infection or Inflammation Cohort - Patients presenting with symptoms indicative of infection or inflammatory disorders.
3. Group C - Cardiovascular Cohort - Patients presenting with symptoms indicative of heart failure or acute coronary syndrome.
4. Group D - Renal Cohort - Patients presenting with symptoms indicative of renal disorders.
5. Group E - Other Cohort. - Patients who are not eligible for any of the above groups.
Exclusion Criteria
* Subject \<18 years of age.
* Vulnerable populations deemed inappropriate for the study by the sites Principal Investigator.
* Patients who have previously been enroled in any LumiraDx NOVEL study in the past 3 months and re-entry would breach the 24mL and or 6 fingersitck maximums.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05568966
Study Brief:
Protocol Section:
NCT05568966